Medico Intercontinental Limited
BSE: MIL · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Medico Intercontinental Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Medico Intercon Limited is an Indian public listed company engaged in the trading and distribution of pharmaceutical products, healthcare consumables, and surgical instruments. The firm acts as an intermediary between manufacturers and healthcare providers to ensure the availability of essential medical goods.
Business Model
The company generates revenue by facilitating the supply chain for medicinal formulations and healthcare supplies, leveraging its distribution network to bridge the gap between manufacturers and end-users.
Management Commentary
Management focuses on enhancing supply chain efficiency and maintaining strict regulatory compliance within the pharmaceutical distribution landscape. The firm aims to capitalise on the rising demand for affordable healthcare solutions in India.
Growth Outlook
Growth is expected to be driven by the expansion of the company's product portfolio to include a wider range of generic medicines and healthcare consumables. The company intends to leverage its trading expertise to capture a larger share of the growing Indian healthcare market.
Key Risks
- Regulatory Compliance. Changes in pharmaceutical distribution regulations or licensing requirements could adversely impact operational continuity.
- Supply Chain Disruptions. Dependency on third-party manufacturers for product availability exposes the company to potential supply chain bottlenecks.
- Market Competition. The highly fragmented nature of the Indian pharmaceutical distribution sector may lead to significant margin pressure.
- Inventory Risk. Fluctuations in demand for specific medical consumables could lead to inventory obsolescence or working capital inefficiencies.
Start your research today
Unlock AI insights, financials, peers and live data on Medico Intercontinental Limited and 5,000+ companies — free.
Peers · Trading & Distributors
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Medico Intercontinental LimitedMIL | ₹28 Cr | — | — | — | 9.5% | — | — | -17.3% |
Veritas (India)VERITAS | ₹445 Cr | 8.63 | 7.06 | -24.1% | 3.9% | 1.9% | 2.7% | -55.4% |
Kothari ProductsKOTHARIPRO | ₹407 Cr | 179.58 | -12.12 | -18.3% | -5.1% | -0.2% | -2.3% | -9.8% |
Rotographics (India) LimitedRGIL | ₹404 Cr | 94.62 | 326.54 | 4987.7% | 3.0% | 12.6% | 17.2% | — |
Polo Queen Industrial and Fintech LimitedPQIF | ₹333 Cr | 141.71 | 64.71 | -5.7% | 7.0% | 1.3% | 2.5% | -79.1% |
Constronics Infra Ltd.CONSTRONIC | ₹61 Cr | — | — | — | 5.5% | — | — | -24.7% |
As of Mar 2026
Financials
Medico Intercontinental Limited
BSE: MIL · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Medico Intercontinental Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Medico Intercon Limited is an Indian public listed company engaged in the trading and distribution of pharmaceutical products, healthcare consumables, and surgical instruments. The firm acts as an intermediary between manufacturers and healthcare providers to ensure the availability of essential medical goods.
Business Model
The company generates revenue by facilitating the supply chain for medicinal formulations and healthcare supplies, leveraging its distribution network to bridge the gap between manufacturers and end-users.
Management Commentary
Management focuses on enhancing supply chain efficiency and maintaining strict regulatory compliance within the pharmaceutical distribution landscape. The firm aims to capitalise on the rising demand for affordable healthcare solutions in India.
Growth Outlook
Growth is expected to be driven by the expansion of the company's product portfolio to include a wider range of generic medicines and healthcare consumables. The company intends to leverage its trading expertise to capture a larger share of the growing Indian healthcare market.
Key Risks
- Regulatory Compliance. Changes in pharmaceutical distribution regulations or licensing requirements could adversely impact operational continuity.
- Supply Chain Disruptions. Dependency on third-party manufacturers for product availability exposes the company to potential supply chain bottlenecks.
- Market Competition. The highly fragmented nature of the Indian pharmaceutical distribution sector may lead to significant margin pressure.
- Inventory Risk. Fluctuations in demand for specific medical consumables could lead to inventory obsolescence or working capital inefficiencies.
Start your research today
Unlock AI insights, financials, peers and live data on Medico Intercontinental Limited and 5,000+ companies — free.
Peers · Trading & Distributors
As of Mar 2026